Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1997-11-17
|
pubmed:abstractText |
In addition to effects of pituitary-derived gonadotropins, human GH modulates and regulates intraovarian reproductive processes in a dose-dependent manner via the endocrine GHRH/GH/insulin-like-growth-factor I (IGF-I) axis. Based on increasing evidence that ovarian regulation involves a complex system of putative para/autocrine factors, we investigated the possibility of gene-selective intraovarian GH/placental lactogen (PL) hormone production, with emphasis on differences between pre- and postmenopause. Analysis of both premenopausal (n = 8) and postmenopausal (n = 10) ovarian-derived messenger ribonucleic acid by reverse transcription-PCR, which amplifies all major gene products of the five-member GH/PL gene cluster GH-N, GH-V, PL-A/B, and PL-L, revealed specific transcripts in all specimens. Their share in gene selective expression by analytical restriction enzyme digestion was determined. The expression pattern of GH/PL messenger ribonucleic acid shows PL-A/B > GH-N, which sets it apart from those of pituitary and placenta. Local production of the respective protein hormones was verified by two time-resolved immunofluorometric assays for human PL-A/B and GH-N; significant amounts of these hormones were detected in cytosolic extracts of premenopausal (n = 6; 555.5 +/- 171 ng PL-A/B and 0.8 +/- 0.6 ng GH-N/g tissue wet wt) and postmenopausal (n = 6; 5.2 +/- 2.7 ng PL-A/B and 0.9 +/- 0.6 ng GH-N/g tissue wet wt) ovaries. No difference was observed between pre- and postmenopausal ovarian GH-N contents, but PL values were 2-3 orders of magnitude lower in postmenopausal tissue (P < 0.001). Serum levels of healthy premenopausal (n = 21) and postmenopausal (n = 16) women were less than 0.02 ng PL/mL. In summary, ovarian-derived GH-N and PL-A/B synthesis correlates well with the established local cascade of GHRH, GHRH receptor, GH receptor, IGF-I, and IGF-I receptor as a putative para/autocrine regulator of ovarian reproductive function.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3337-41
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9329365-Adult,
pubmed-meshheading:9329365-Aged,
pubmed-meshheading:9329365-Female,
pubmed-meshheading:9329365-Fluoroimmunoassay,
pubmed-meshheading:9329365-Human Growth Hormone,
pubmed-meshheading:9329365-Humans,
pubmed-meshheading:9329365-Middle Aged,
pubmed-meshheading:9329365-Multigene Family,
pubmed-meshheading:9329365-Ovary,
pubmed-meshheading:9329365-Placental Lactogen,
pubmed-meshheading:9329365-Postmenopause,
pubmed-meshheading:9329365-Pregnancy,
pubmed-meshheading:9329365-Premenopause,
pubmed-meshheading:9329365-Transcription, Genetic
|
pubmed:year |
1997
|
pubmed:articleTitle |
Selective growth hormone/placental lactogen gene transcription and hormone production in pre- and postmenopausal human ovaries.
|
pubmed:affiliation |
Institute for Biomedical Aging Research, Austrian Academy of Sciences, Innsbruck, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|